Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : This month symbols : Abbv save search
Pulmonary Embolism Therapeutics Market size to grow at a CAGR of 9.52% from 2022 to 2027, Technavio
Published: 2024-04-17 (Crawled : 00:00) - prnewswire.com
ABBV | $167.2 1.8% 1.3M
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
AMGN | $265.48 0.53% 360K
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
therapeutics market
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -1.75%
H: 0.85%
C: 0.85%
AZNCF | $140.15 560
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: -2.52%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
GSK | $39.44 -0.4% 560K
|
Health Technology
|
| O: -1.19%
H: 0.52%
C: -0.17%
BAX | News | $39.56 0.1% 520K
|
Health Technology
|
| O: -0.1%
H: 0.13%
C: -1.08%
ABBV | $167.2 1.8% 1.3M
|
Health Technology
|
| O: 0.32%
H: 0.96%
C: 0.22%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: -2.13%
H: 0.0%
C: 0.0%
BMRN | News S | $91.03 0.62% 280K
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: -0.64%
H: 0.45%
C: -0.04%
AMGN | $265.48 0.53% 360K
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
set therapeutics market
Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -0.53%
H: 0.61%
C: 0.61%
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $167.2 1.8% 1.3M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -1.73%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
research global gastrointestinal therapeutics
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
ABBV | $167.2 1.8% 1.3M
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: 0.0%
qulipta abbvie treatment for migraine
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
AZNCF | $140.15 560
|
Health Technology
|
| O: -3.43%
H: 6.21%
C: 6.21%
VTRS | $11.22 1.08% 510K
|
Health Technology
|
| O: -0.25%
H: 1.1%
C: -0.17%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: -0.05%
H: 0.43%
C: -0.27%
BMY | $48.145 0.64% 2.5M
|
Health Technology
|
| O: -0.08%
H: 0.04%
C: -0.35%
BHC | $8.735 0.87% 570K
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -7.27%
ABBV | $167.2 1.8% 1.3M
|
Health Technology
|
| O: 0.77%
H: 1.63%
C: 0.35%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: 0.18%
H: 0.3%
C: 0.19%
eczema dermatitis set therapeutics market
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
Published: 2024-04-08 (Crawled : 12:30) - globenewswire.com
ABBV | $167.2 1.8% 1.3M
|
Health Technology
|
| O: 0.77%
H: 1.63%
C: 0.35%
CHRS | $2.14 -0.47% 360K
|
Health Technology
|
| O: 0.82%
H: 3.88%
C: 2.45%
chs-1000 preclinical for meeting
AbbVie to Host First-Quarter 2024 Earnings Conference Call
Published: 2024-04-04 (Crawled : 12:00) - prnewswire.com
ABBV | $167.2 1.8% 1.3M
|
Health Technology
|
| O: -1.86%
H: 0.03%
C: -5.49%
conference abbvie
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
NXGL | $2.255 830
|
Manufacturing
|
| O: 1.83%
H: 0.0%
C: -19.42%
ABBV | $167.2 1.8% 1.3M
|
Health Technology
|
| O: -0.12%
H: 0.01%
C: -0.62%
year revenue
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | $0.7995 99.88% 73M
|
Finance
BPTH | $6.21 91.67% 58M
|
Health Technology
INVO | $1.36 78.95% 3.6M
|
Health Technology
TIRX | $0.8258 70.34% 50M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
VTNR S | $1.295 32.25% 5.5M
|
Industrial Services
ALRN | $5.53 30.12% 250K
|
Health Technology
SMSI 4 | $2.53 29.74% 510K
|
Technology Services
HOLO | $2.86 27.68% 28M
|
Your saved searches
Save your searches and get alerts when important news are released.